Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Debt Ratio: 2019-2025

Historic Debt Ratio for Tg Therapeutics (TGTX) over the last 7 years, with Sep 2025 value amounting to 0.24.

  • Tg Therapeutics' Debt Ratio fell 42.55% to 0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24, marking a year-over-year decrease of 42.55%. This contributed to the annual value of 0.42 for FY2024, which is 39.29% up from last year.
  • As of Q3 2025, Tg Therapeutics' Debt Ratio stood at 0.24, which was down 31.37% from 0.35 recorded in Q2 2025.
  • Tg Therapeutics' 5-year Debt Ratio high stood at 0.49 for Q1 2023, and its period low was 0.04 during Q3 2021.
  • For the 3-year period, Tg Therapeutics' Debt Ratio averaged around 0.35, with its median value being 0.35 (2025).
  • In the last 5 years, Tg Therapeutics' Debt Ratio plummeted by 80.85% in 2021 and then spiked by 735.99% in 2022.
  • Tg Therapeutics' Debt Ratio (Quarterly) stood at 0.18 in 2021, then surged by 105.88% to 0.37 in 2022, then fell by 17.34% to 0.30 in 2023, then spiked by 39.29% to 0.42 in 2024, then tumbled by 42.55% to 0.24 in 2025.
  • Its Debt Ratio stands at 0.24 for Q3 2025, versus 0.35 for Q2 2025 and 0.37 for Q1 2025.